Aurora Cannabis, the Canada-based medical cannabis company, has launched medical cannabis concentrates to patients in the United Kingdom (UK).
"As a company dedicated to patient care and ensuring we regularly listen to patient feedback – we recognized a real need for a convenient, and discreet consumption option and are excited to introduce a new cannabis format at a promised level of quality," said Trisha Cassidy, Managing Director Aurora UK and Ireland. "Our launch of inhalable cannabis cartridges are another step forward in our mission to provide physicians with a larger variety of high-quality medical cannabis that can meet the growing needs and wishes of patients here in the UK. We look forward to receiving feedback from physicians and patients with this expanded offering."
The two novel Aurora 1.2g resin cartridges have been developed from two proprietary cultivars: Sourdough (indica) and Electric Honeydew (sativa). The inhalation method of these cartridges offers a solution for fast and controlled delivery of medical cannabis.
